INS and infection: Its clinical impact is profound, being associated with accelerated pulmonary decline, heightened infection susceptibility, nutritional deterioration, and increased mortality.A customized and individualized insulin therapy remains the recommended treatment for children and adolescents with CFRD (21), whereas there is only limited evidence for use of oral hypoglycemic agents (22).